FluoroType^® CT

As highly specific nucleic acid amplification test, FluoroType^® CT allows the reliable detection within three hours of Chlamydia trachomatis directly from cervical swabs, first-void urine and ejaculate. To ensure a sensitive pathogen identification, FluoroType^® CT simultaneously detects two different target sequences, one within the genome and another one in the cryptic plasmid. Therefore, the new Chlamydia trachomatis variant, which was discovered in Sweden in 2006, as well as cryptic plasmid-free chlamydia can be detected.

The assay can be implemented in your laboratory routine in an easy and cost-efficient manner based. Furthermore, DNA extracted for determining Chlamydia trachomatis can also be used for FluoroType^® NG to identify Neisseria gonorrhoeae infections. Both tests can simultaneously be processed with FluoroCycler^® XT and  FluoroCycler^® 12.

For FluoroType^® CT, bacterial DNA extraction from the sample material is manual with FluoroLyse or automated with GenoXtract^® combined with GXT NA Extraction Kit, in easy to use cartridges, adapted to each throughput with validation on FluoroCyler^® 12 as well as FluoroCycler^® XT. The evaluation and result interpretation is performed by the FluoroSoftware^®. This guarantees maximum user-friendliness and efficient laboratory diagnostics with impeccable results at a glance.

• High sensitivity and specificity: The simultaneous detection of two highly conserved target sequence, one within the genome and one within the cryptic plasmid, allows sensitive and reliable results.
• Cost-efficient: As a nucleic acid amplification test (NAT) the FluoroType^® CT is a reliable, cost-effective screening tool for Chlamydia trachomatis.
• Reliable: The internal control ensures a successful extraction and also serves as inhibition control for the amplification. Valid results are therefore guaranteed.
• Compatible with NG test: If necessary, DNA isolated with the FluoroLyse kit can be used for the FluoroType^® NG and examined for the presence of Neisseria gonorrhoeae. Consequently, you don’t have to request any further patient specimen or repeat the DNA extraction procedure.
• User-friendly: A ready-to-use amplification mix already including the Taq polymerase is provided with each kit. Amplification and detection run fully automated. The evaluation is done by the user friendly FluoroSoftware^®.
• CE-marked IVD: No need for elaborate validation studies.